SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-080032
Filing Date
2022-07-15
Accepted
2022-07-15 08:06:12
Documents
15
Period of Report
2022-07-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218235-2_8k.htm   iXBRL 8-K 34958
2 EXHIBIT 3.1 tm2218235d2_ex3-1.htm EX-3.1 47342
3 EXHIBIT 99.1 tm2218235d2_ex99-1.htm EX-99.1 13615
7 GRAPHIC image_001.jpg GRAPHIC 5595
  Complete submission text file 0001104659-22-080032.txt   300168

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20220711.xsd EX-101.SCH 3060
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220711_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220711_pre.xml EX-101.PRE 22614
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2218235-2_8k_htm.xml XML 3728
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 221084298
SIC: 2834 Pharmaceutical Preparations